SI-BONE, which manufactures spinal implants for the alleviation of lower back pain, filed on Thursday with the SEC to raise up to $98 million in an initial public offering.
The Santa Clara, CA-based company was founded in 2008 and booked $52 million in revenue for the 12 months ended June 30, 2018. It plans to list on the Nasdaq under the symbol SIBN. Morgan Stanley and BofA Merrill Lynch are the joint bookrunners on the deal. No pricing terms were disclosed.
